oncology market
Arix invests in oncology innovator VelosBio
October 01 by Pharmaceuticals & Biotechnology Editor
UK health specialist Arix has led the investment in new ADC oncology treatment developed by next-generation oncology firm VelosBio.
Oncology Market Leaders Must Look to Clinical Development for Future Growth
November 17 by Pharma IQOver recent years cancer drugs have moved from the traditional chemotherapies, which provided significant side effects, to more targeted therapies. However, according to a recent Reuters rep...
